Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 5, 2025 20:36 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,904 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029685 · wk-form4_1749155604.xml · derivative · entry 2 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,904 Underlying: Ordinary Shares · 8,904 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 2,226 on June 3, 2026, 2,226 on June 3, 2027, 2,226 on June 5, 2028 and 2,226 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:36 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantOrdinary Shares | 2,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029685 · wk-form4_1749155604.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,089 F1 · balance_after: As of June 3, 2025, 9,578 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 692 on October 1, 2025; 2,313 on June 1, 2026; 2,028 on June 2, 2026; 2,040 on June 4, 2027 and 2,505 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:46 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,728 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029701 · wk-form4_1749156190.xml · derivative · entry 2 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,728 Underlying: Ordinary Shares · 6,728 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 1,682 on June 3, 2026, 1,682 on June 3, 2027, 1,682 on June 5, 2028 and 1,682 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:46 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantOrdinary Shares | 1,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029701 · wk-form4_1749156190.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,930 F1 · balance_after: As of June 3, 2025, 4,027 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 513 on June 4, 2025; 373 on May 31, 2026; 225 on June 2, 2026; 630 on June 3, 2026; 513 on June 4, 2026; 630 on June 3, 2027; 513 on June 4, 2027 and 630 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:41 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,316 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029691 · wk-form4_1749155777.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,316 Underlying: Ordinary Shares · 2,316 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 579 on June 3, 2026, 579 on June 3, 2027, 579 on June 5, 2028 and 579 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:41 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029691 · wk-form4_1749155777.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,287 F1 · balance_after: As of June 3, 2025, 1,782 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,392 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029690 · wk-form4_1749155750.xml · derivative · entry 3 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,392 Underlying: Ordinary Shares · 10,392 shares Expires 2035-06-03 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,598 on June 3, 2026, 2,598 on June 3, 2027, 2,598 on June 5, 2028 and 2,598 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantOrdinary Shares | 2,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029690 · wk-form4_1749155750.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,730 F1 · balance_after: As of June 3, 2025, 10,830 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026; 2,379 on June 4, 2027 and 2,922 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,360 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029689 · wk-form4_1749155829.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,360 Underlying: Ordinary Shares · 13,360 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 3,340 on June 3, 2026, 3,340 on June 3, 2027, 3,340 on June 5, 2028 and 3,340 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:39 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 3,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029689 · wk-form4_1749155829.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,163 F1 · balance_after: As of June 3, 2025, 10,089 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:37 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,908 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029686 · wk-form4_1749155804.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,908 Underlying: Ordinary Shares · 7,908 shares Expires 2035-06-03 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,977 on June 3, 2026, 1,977 on June 3, 2027, 1,977 on June 5, 2028 and 1,977 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:37 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 2,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029686 · wk-form4_1749155804.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,232 F1 · balance_after: As of June 3, 2025, 7,647 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 741 on June 3, 2026; 1,141 on June 4, 2026; 741 on June 3, 2027; 1,141 on June 4, 2027 and 741 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:34 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 63,328 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029680 · wk-form4_1749155573.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,328 Underlying: Ordinary Shares · 63,328 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 15,832 on June 3, 2026, 15,832 on June 3, 2027, 15,832 on June 5, 2028 and 15,832 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:34 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantOrdinary Shares | 17,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029680 · wk-form4_1749155573.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,932 F1 · balance_after: As of June 3, 2025, 37,626 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027 and 5,937 on June 5, 2028. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:32 UTC |
Burton Karen LVP & CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,944 | $0.00 Strike: $267.66 | $0.00 |
DisclosureSEC source: 0001628280-25-029676 · wk-form4_1749155407.xml · derivative · entry 2 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,944 Underlying: Ordinary Shares · 6,944 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 1,736 on June 3, 2026, 1,736 on June 3, 2027, 1,736 on June 5, 2028 and 1,736 on June 4, 2029. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:32 UTC |
Burton Karen LVP & CAO
|
GrantOrdinary Shares | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029676 · wk-form4_1749155407.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,086 F1 · balance_after: As of June 3, 2025, 3,522 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 651 on June 3, 2026; 225 on June 2, 2026; 306 on June 4, 2026; 651 on June 3, 2027; 306 on June 4, 2027 and 651 on June 5, 2028. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:32 UTC |
Fraser Mary ClareSVP & Chief HRO
|
Tax withholdingOrdinary Shares | 548 | $242.08 | $132,659.84 |
DisclosureSEC source: 0001628280-25-029349 · wk-form4_1749069106.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,584 F1 · shares: 548 shares were withheld from the 1,836 restricted shares that vested on June 2, 2025. These 548 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,836 ordinary shares were awarded to Ms. Fraser on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 7,073 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 692 on October 1, 2025; 2,313 on June 1, 2026; 2,028 on June 2, 2026 and 2,040 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 127 | $242.08 | $30,744.16 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,958 F4 · shares: 127 shares were withheld from the 352 restricted shares that vested on June 2, 2025. These 127 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 352 ordinary shares were awarded to Ms. Madsen on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 129 | $242.08 | $31,228.32 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,085 F3 · shares: 129 shares were withheld from the 360 restricted shares that vested on June 2, 2025. These129 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:34 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 207 | $242.08 | $50,110.56 |
DisclosureSEC source: 0001628280-25-029355 · wk-form4_1749069235.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,214 F1 · shares: 207 shares were withheld from the 578 restricted shares that vested on June 2, 2025. These 207 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 578 ordinary shares were awarded to Ms. Madsen on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,700 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 253 | $242.08 | $61,246.24 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,407 F4 · shares: 253 shares were withheld from the 846 restricted shares that vested on June 2, 2025. These 253 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 846 ordinary shares were awarded to Mr. Zangerle on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 245 | $242.08 | $59,309.60 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,660 F3 · shares: 245 shares were withheld from the 819 restricted shares that vested on June 2, 2025. These 245 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 346 | $242.08 | $83,759.68 |
DisclosureSEC source: 0001628280-25-029365 · wk-form4_1749069445.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,905 F1 · shares: 346 shares were withheld from the 1,157 restricted shares that vested on June 2, 2025. These 346 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,157 ordinary shares were awarded to Mr. Zangerle on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 6,333 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows:1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 42 | $242.08 | $10,167.36 |
DisclosureSEC source: 0001628280-25-029362 · wk-form4_1749069333.xml · nonDerivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,636 F4 · shares: 42 shares were withheld from the 141 restricted shares that vested on June 2, 2025. These 42 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 141 ordinary shares were awarded to Mr. Tamaro on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,131 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 221 on June 4, 2026 and 221 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 51 | $242.08 | $12,346.08 |
DisclosureSEC source: 0001628280-25-029362 · wk-form4_1749069333.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,678 F3 · shares: 51 shares were withheld from the 144 restricted shares that vested on June 2, 2025. These 51 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 144 ordinary shares were awarded to Mr. Tamaro on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,131 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 221 on June 4, 2026 and 221 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 72 | $242.08 | $17,429.76 |
DisclosureSEC source: 0001628280-25-029362 · wk-form4_1749069333.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,729 F1 · shares: 72 shares were withheld from the 241 restricted shares that vested on June 2, 2025. These 72 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 241 ordinary shares were awarded to Mr. Tamaro on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,131 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 221 on June 4, 2026 and 221 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 169 | $242.08 | $40,911.52 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,009 F4 · shares: 169 shares were withheld from the 564 restricted shares that vested on June 2, 2025. These 169 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 564 ordinary shares were awarded to Mr. Tokich on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 172 | $242.08 | $41,637.76 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,178 F3 · shares: 172 shares were withheld from the 573 restricted shares that vested on June 2, 2025. These 172 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 573 ordinary shares were awarded to Mr. Tokich on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:37 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 386 | $242.08 | $93,442.88 |
DisclosureSEC source: 0001628280-25-029364 · wk-form4_1749069385.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,350 F1 · shares: 386 shares were withheld from the 1,293 restricted shares that vested on June 2, 2025. These 386 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,293 ordinary shares were awarded to Mr. Tokich on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 5,424 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:35 UTC |
Majors Cary LSVP and President, Healthcare
|
Tax withholdingOrdinary Shares | 564 | $242.08 | $136,533.12 |
DisclosureSEC source: 0001628280-25-029358 · wk-form4_1749069283.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,808 F1 · shares: 564 shares were withheld from the 1,964 restricted shares that vested on June 2, 2025. These 564 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,964 ordinary shares were awarded to Mr. Majors on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 7,908 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 68 | $242.08 | $16,461.44 |
DisclosureSEC source: 0001628280-25-029351 · wk-form4_1749069164.xml · nonDerivative · entry 3 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,040 F5 · shares: 68 shares were withheld from the 225 restricted shares that vested on June 2, 2025. These 68 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 225 ordinary shares were awarded to Mr. Kohler on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,137 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 513 on June 4, 2025; 373 on May 31, 2026; 225 on June 2, 2026; 513 on June 4, 2026 and 513 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 39 | $242.08 | $9,441.12 |
DisclosureSEC source: 0001628280-25-029351 · wk-form4_1749069164.xml · nonDerivative · entry 2 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,108 F4 · shares: 39 shares were withheld from the 131 restricted shares that vested on June 2, 2025. These 39 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 131 ordinary shares were awarded to Mr. Kohler on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,137 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 513 on June 4, 2025; 373 on May 31, 2026; 225 on June 2, 2026; 513 on June 4, 2026 and 513 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 112 | $242.08 | $27,112.96 |
DisclosureSEC source: 0001628280-25-029351 · wk-form4_1749069164.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,147 F1 · shares: 112 shares were withheld from the 373 restricted shares that vested on June 2, 2025. These 112 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 373 ordinary shares were awarded to Mr. Kohler on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 2,137 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 513 on June 4, 2025; 373 on May 31, 2026; 225 on June 2, 2026; 513 on June 4, 2026 and 513 on June 4, 2027. F3 · balance_after: The shares beneficially owned were erroneously reported in prior Form 4s. The shares held are being corrected in this Form 4 to reflect the current amount of shares beneficially owned. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 708 | $242.08 | $171,392.64 |
DisclosureSEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,121 F4 · shares: 708 shares were withheld from the 2,369 restricted shares that vested on June 2, 2025. These 708 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,369 ordinary shares were awarded to Mr. Carestio on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 452 | $242.08 | $109,420.16 |
DisclosureSEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,829 F3 · shares: 452 shares were withheld from the 1,514 restricted shares that vested on June 2, 2025. These 452 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,514 ordinary shares were awarded to Mr. Carestio on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 1,905 | $242.08 | $461,162.40 |
DisclosureSEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,281 F1 · shares: 1,905 shares were withheld from the 4,308 restricted shares that vested on June 2, 2025. These 1,905 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,308 ordinary shares were awarded to Mr. Carestio on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 68 | $242.08 | $16,461.44 |
DisclosureSEC source: 0001628280-25-029346 · wk-form4_1749069023.xml · nonDerivative · entry 3 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,133 F4 · shares: 68 shares were withheld from the 225 restricted shares that vested on June 2, 2025. These 68 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 225 ordinary shares were awarded to Ms. Burton on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,569 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 225 on June 2, 2026; 306 on June 4, 2026 and 306 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 59 | $242.08 | $14,282.72 |
DisclosureSEC source: 0001628280-25-029346 · wk-form4_1749069023.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,201 F3 · shares: 59 shares were withheld from the 196 restricted shares that vested on June 2, 2025. These 59 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 196 ordinary shares were awarded to Ms. Burton on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,569 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 225 on June 2, 2026; 306 on June 4, 2026 and 306 on June 4, 2027. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:30 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 102 | $242.08 | $24,692.16 |
DisclosureSEC source: 0001628280-25-029346 · wk-form4_1749069023.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,260 F1 · shares: 102 shares were withheld from the 340 restricted shares that vested on June 2, 2025. These 102 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 340 ordinary shares were awarded to Ms. Burton on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 1,569 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 225 on June 2, 2026; 306 on June 4, 2026 and 306 on June 4, 2027. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:31 UTC |
Majors Cary LSVP and President, Healthcare
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,828 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001628280-25-027284 · wk-form4_1747945868.xml · derivative · entry 5 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,828 shares Expires 2029-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:31 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 4,581 | $250.71 | $1,148,502.51 |
DisclosureSEC source: 0001628280-25-027284 · wk-form4_1747945868.xml · nonDerivative · entry 3 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,372 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $250.50 to $251.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:31 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 8,247 | $249.73 | $2,059,523.31 |
DisclosureSEC source: 0001628280-25-027284 · wk-form4_1747945868.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,953 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $249.46 to $250.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:31 UTC |
Majors Cary LSVP and President, Healthcare
|
Exercise / conversionOrdinary Shares | 12,828 | $147.05 | $1,886,357.40 |
DisclosureSEC source: 0001628280-25-027284 · wk-form4_1747945868.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of May 20, 2025, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 21:30 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 1,682 | $217.32 | $365,532.24 |
DisclosureSEC source: 0000950170-24-131534 · ownership.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,372 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $217.32 to $217.40 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of ordinary shares sold at each separate price. F2 · balance_after: As of November 27, 2024, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:34 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 250 | $235.78 | $58,945.00 |
DisclosureSEC source: 0001628280-24-041922 · wk-form4_1727901248.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,421 F1 · shares: 250 shares were withheld from the 493 restricted shares that vested on October 1, 2024. These 250 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 3,990 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:37 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 91 | $235.78 | $21,455.98 |
DisclosureSEC source: 0001628280-24-041932 · wk-form4_1727901421.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,251 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 1, 2024. These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 9,155 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 1,376 on June 4, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,376 on June 4, 2026 and 1,376 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:36 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 194 | $235.78 | $45,741.32 |
DisclosureSEC source: 0001628280-24-041929 · wk-form4_1727901368.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,736 F1 · shares: 194 shares were withheld from the 432 restricted shares that vested on October 1, 2024. These 194 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 432 ordinary shares were awarded to Mr. Tokich on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 7,854 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:35 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 78 | $235.78 | $18,390.84 |
DisclosureSEC source: 0001628280-24-041925 · wk-form4_1727901304.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,801 F1 · shares: 78 shares were withheld from the 258 restricted shares that vested on October 1, 2024. These 258 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 258 ordinary shares were awarded to Mr. Tamaro on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 1,657 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 2, 2025; 144 on June 2, 2025; 141 on June 2, 2025; 221 on June 4, 2025; 86 on October 1, 2025; 241 on June 1, 2026; 141 on June 2, 2026; 221 on June 4, 2026 and 221 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:33 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 130 | $235.78 | $30,651.40 |
DisclosureSEC source: 0001628280-24-041920 · wk-form4_1727901187.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,186 F1 · shares: 130 shares were withheld from the 289 restricted shares that vested on October 1, 2024. These 130 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Carestio on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 28,006 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:32 UTC |
Burton Karen LVP & CAO
|
Tax withholdingOrdinary Shares | 26 | $235.78 | $6,130.28 |
DisclosureSEC source: 0001628280-24-041918 · wk-form4_1727901123.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,362 F1 · shares: 26 shares were withheld from the 86 restricted shares that vested on October 1, 2024. These 26 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 86 ordinary shares were awarded to Ms. Burton on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 2,330 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 306 on June 4, 2025; 86 on October 1, 2025; 340 on June 1, 2026; 225 on June 2, 2026; 306 on June 4, 2026 and 306 on June 4, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.